Rajiv D. Machado

11.0k total citations · 6 hit papers
26 papers, 4.5k citations indexed

About

Rajiv D. Machado is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Rajiv D. Machado has authored 26 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Rajiv D. Machado's work include Pulmonary Hypertension Research and Treatments (23 papers), Vascular Anomalies and Treatments (6 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). Rajiv D. Machado is often cited by papers focused on Pulmonary Hypertension Research and Treatments (23 papers), Vascular Anomalies and Treatments (6 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). Rajiv D. Machado collaborates with scholars based in United Kingdom, United States and France. Rajiv D. Machado's co-authors include Richard C. Trembath, Nicholas W. Morrell, Jennifer R. Thomson, James E. Loyd, Michael W. Pauciulo, William C. Nichols, John A. Phillips, Kirk B. Lane, Carl Atkinson and Laura Southgate and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Medicine.

In The Last Decade

Rajiv D. Machado

24 papers receiving 4.5k citations

Hit Papers

Heterozygous germline mutations in BMPR2, encoding a TGF-... 2000 2026 2008 2017 2000 2010 2002 2001 2013 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension
    2000 1.1k citations Rajiv D. Machado, Michael W. Pauciulo et al. profile →
  2. Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension
    2010 588 citations Elaine Soon, Alan Holmes et al. Circulation profile →
  3. Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor
    2002 525 citations Carl Atkinson, Paul D. Upton et al. Circulation profile →
  4. Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia
    2001 518 citations Richard C. Trembath, Jennifer R. Thomson et al. New England Journal of Medicine profile →
  5. Genetics and Genomics of Pulmonary Arterial Hypertension
    2013 359 citations Florent Soubrier, Wendy K. Chung et al. Journal of the American College of Cardiology profile →
  6. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
    2015 347 citations Lü Long, Mark L. Ormiston et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajiv D. Machado United Kingdom 21 3.8k 1.4k 1.1k 840 461 26 4.5k
Jennifer R. Thomson United Kingdom 10 2.5k 0.7× 873 0.6× 625 0.6× 657 0.8× 250 0.5× 10 2.8k
Florence Coulet France 31 1.3k 0.4× 427 0.3× 843 0.8× 623 0.7× 486 1.1× 102 3.3k
Christine Mallet France 24 673 0.2× 456 0.3× 1.5k 1.3× 586 0.7× 366 0.8× 29 3.0k
Mark L. Ormiston Canada 23 1.3k 0.3× 484 0.3× 940 0.8× 208 0.2× 298 0.6× 39 2.3k
Neil Davie United Kingdom 18 1.6k 0.4× 880 0.6× 415 0.4× 248 0.3× 270 0.6× 41 2.0k
G Tobelem France 35 401 0.1× 447 0.3× 1.4k 1.3× 371 0.4× 587 1.3× 99 3.5k
José A. Miranda‐Filloy Spain 29 1.1k 0.3× 245 0.2× 559 0.5× 379 0.5× 170 0.4× 91 3.0k
Sadakatsu Ikeda Japan 24 627 0.2× 507 0.4× 2.3k 2.1× 98 0.1× 539 1.2× 63 3.5k
Nicolas Ricard France 15 698 0.2× 226 0.2× 669 0.6× 227 0.3× 242 0.5× 18 1.5k
Evangelia Pardali Netherlands 30 533 0.1× 253 0.2× 2.2k 2.0× 341 0.4× 328 0.7× 47 3.7k

Countries citing papers authored by Rajiv D. Machado

Since Specialization
Citations

This map shows the geographic impact of Rajiv D. Machado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajiv D. Machado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajiv D. Machado more than expected).

Fields of papers citing papers by Rajiv D. Machado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajiv D. Machado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajiv D. Machado. The network helps show where Rajiv D. Machado may publish in the future.

Co-authorship network of co-authors of Rajiv D. Machado

This figure shows the co-authorship network connecting the top 25 collaborators of Rajiv D. Machado. A scholar is included among the top collaborators of Rajiv D. Machado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajiv D. Machado. Rajiv D. Machado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eichstaedt, Christina A., Rajiv D. Machado, Stefan Gräf, et al.. (2025). Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar. Human Mutation. 2025(1). 2475635–2475635.
2.
Southgate, Laura, Rajiv D. Machado, Stefan Gräf, & Nicholas W. Morrell. (2019). Molecular genetic framework underlying pulmonary arterial hypertension. Nature Reviews Cardiology. 17(2). 85–95. 198 indexed citations
3.
Long, Lü, Mark L. Ormiston, Xudong Yang, et al.. (2015). Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. Nature Medicine. 21(7). 777–785. 347 indexed citations breakdown →
4.
Southgate, Laura, Maja Sukalo, Edward J. Taylor, et al.. (2015). Haploinsufficiency of the NOTCH1 Receptor as a Cause of Adams–Oliver Syndrome With Variable Cardiac Anomalies. Circulation Cardiovascular Genetics. 8(4). 572–581. 70 indexed citations
5.
Soubrier, Florent, Wendy K. Chung, Rajiv D. Machado, et al.. (2013). Genetics and Genomics of Pulmonary Arterial Hypertension. Journal of the American College of Cardiology. 62(25). D13–D21. 359 indexed citations breakdown →
6.
Ormiston, Mark L., Chiwen Chang, Lü Long, et al.. (2012). Impaired Natural Killer Cell Phenotype and Function in Idiopathic and Heritable Pulmonary Arterial Hypertension. Circulation. 126(9). 1099–1109. 87 indexed citations
7.
8.
He, Yi, Jason J. Northey, Martin Primeau, et al.. (2010). CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion. Oncogene. 30(9). 1032–1045. 28 indexed citations
9.
Soon, Elaine, Alan Holmes, Carmen Treacy, et al.. (2010). Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension. Circulation. 122(9). 920–927. 588 indexed citations breakdown →
10.
11.
Machado, Rajiv D., Oliver Eickelberg, C. Gregory Elliott, et al.. (2009). Genetics and Genomics of Pulmonary Arterial Hypertension. Journal of the American College of Cardiology. 54(1). S32–S42. 266 indexed citations
12.
Aldred, Micheala A., Rajiv D. Machado, Victoria James, Nicholas W. Morrell, & Richard C. Trembath. (2007). Characterization of the BMPR2 5′-Untranslated Region and a Novel Mutation in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 176(8). 819–824. 32 indexed citations
13.
Suntharalingam, J, Rajiv D. Machado, Linda Sharples, et al.. (2007). Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension. Thorax. 62(7). 617–622. 33 indexed citations
14.
Machado, Rajiv D., Rolf Koehler, Eric W. Glissmeyer, et al.. (2006). Genetic Association of the Serotonin Transporter in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 173(7). 793–797. 62 indexed citations
15.
Sankelo, Marja, Rajiv D. Machado, Rachel Harrison, et al.. (2005). BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension. Human Mutation. 26(2). 119–124. 25 indexed citations
16.
17.
Humbert, Marc, Philippe Labrune, Olivier Sitbon, et al.. (2002). Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. European Respiratory Journal. 20(1). 59–65. 45 indexed citations
18.
Thomson, Jill R., Rajiv D. Machado, Michael W. Pauciulo, et al.. (2001). Familial and sporadic primary pulmonary hypertension is caused by BMPR2 gene mutations resulting in haploinsufficiency of the bone morphogenetic protein tùype II receptor. The Journal of Heart and Lung Transplantation. 20(2). 149–149. 40 indexed citations
19.
Trembath, Richard C., Jennifer R. Thomson, Rajiv D. Machado, et al.. (2001). Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia. New England Journal of Medicine. 345(5). 325–334. 518 indexed citations breakdown →
20.
Machado, Rajiv D., Michael W. Pauciulo, Neale Fretwell, et al.. (2000). A Physical and Transcript Map Based upon Refinement of the Critical Interval for PPH1, a Gene for Familial Primary Pulmonary Hypertension. Genomics. 68(2). 220–228. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer R. Thomson Breakdown of academic impact, for papers by Florence Coulet Breakdown of academic impact, for papers by Christine Mallet Breakdown of academic impact, for papers by Mark L. Ormiston Breakdown of academic impact, for papers by Neil Davie Breakdown of academic impact, for papers by G Tobelem Breakdown of academic impact, for papers by José A. Miranda‐Filloy Breakdown of academic impact, for papers by Sadakatsu Ikeda Breakdown of academic impact, for papers by Nicolas Ricard Breakdown of academic impact, for papers by Evangelia Pardali
Rankless by CCL
2026